BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 2, 2020
View Archived Issues
Junshi Biosciences provides updates on JS-108 and JS-006 studies
Read More
FDA accepts IND for CERC-803 to treat leukocyte adhesion deficiency type II
Read More
Phase III ACTIVATE trial of mitapivat in PK deficiency meets primary endpoint
Read More
RS-5614 studied in investigator-initiated trial for severe COVID-19
Read More
Combination enhances solid tumor immunotherapy
Read More
Edesa initiates phase II/III study of EB-05 for hospitalized patients with COVID-19
Read More
Investigator-initiated trial to study Carragelose nasal spray for COVID-19 prophylaxis
Read More
Preliminary week 18 phase Ib/IIa data reported for HST-001 in androgenic alopecia
Read More
Rafael Pharmaceuticals to launch phase II study of CPI-613 in clear cell sarcoma of soft tissue
Read More
Agenus initiates phase II expansion of AGEN-1181 plus balstilimab in colon cancer
Read More
DMC completes positive safety review of CYNKCOVID study
Read More
Korea Research Institute of Bioscience and Biotechnology patents peptides for IBD
Read More
New USP19 inhibitors described by Integral Health Holdings, Valo Early Discovery
Read More
Aligos Therapeutics discovers STING agonists
Read More
FDA grants accelerated approval to Gavreto for advanced or metastatic RET-altered thyroid cancers
Read More
Prodrugs of TLR7 and TLR8 antagonists identified at Bristol Myers Squibb
Read More
New JAK inhibitors patented by Vimalan Biosciences
Read More
FDA approves Xolair to treat nasal polyps
Read More
Hetlioz approved in U.S. for nighttime sleep disturbances in Smith-Magenis syndrome
Read More
Investigators develop a swine model of abdominal aortic aneurysm
Read More
Targovax reports phase I data on ONCOS-102 with pembrolizumab in advanced melanoma
Read More
Novel rat models of doxorubicin-induced left ventricular dysfunction
Read More
A-3907 targets bile acid transport in the intestine and kidney for treating NASH, fibrosis
Read More
Ashvattha Therapeutics presents htHD-FXRa for treating hepatic and biliary disorders
Read More
Akeso reports preliminary data on cadonilimab for MSI-H advanced solid tumors
Read More
FDA clears IND for phase I study of DHOHD inhibitor RP-7214 for COVID-19
Read More
NEPTUNE study of OV-101 for Angelman syndrome misses primary endpoint
Read More
U.K. approval for Pfizer and BioNTech's COVID-19 mRNA vaccine BNT-162b2
Read More
IND for phase I study of SSAO/VAP-1 inhibitor TT-01025 cleared in U.S.
Read More